CannaPharmaRX, Inc.
General ticker "CPMD" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $3.3M (TTM average)
CannaPharmaRX, Inc. does not follow the US Stock Market performance with the rate: -16.3%.
Estimated limits based on current volatility of 34.0%: low 0.00$, high 0.00$
Factors to consider:
- Total employees count: 21 (+162.5%) as of 2023
- Top business risk factors: High dependence on financing and potential inability to secure future capital, Liquidity and credit risks, Strategic risks and growth management, Acquisition/divestiture risks, Labor/talent shortage/retention
- Current price 15.9% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.00$, 0.01$]
- 2025-12-31 to 2026-12-31 estimated range: [0.00$, 0.01$]
Short-term CPMD quotes
Long-term CPMD plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.82MM |
| Operating Expenses | $5.21MM | $1.58MM | $4.43MM |
| Operating Income | $-5.21MM | $-1.58MM | $-3.61MM |
| Non-Operating Income | $-3.32MM | $5.27MM | $-6.30MM |
| Interest Expense | $2.29MM | $1.70MM | $2.26MM |
| Income(Loss) | $-8.53MM | $3.69MM | $-9.91MM |
| Profit(Loss)* | $-8.53MM | $3.69MM | $-9.91MM |
| Stockholders Equity | $-17.34MM | $-12.15MM | $-19.81MM |
| Inventory | $0.07MM | $1.13MM | $1.00MM |
| Assets | $6.34MM | $11.75MM | $10.84MM |
| Operating Cash Flow | $-1.45MM | $-2.27MM | $-1.70MM |
| Capital expenditure | $0.12MM | $0.08MM | $0.00MM |
| Investing Cash Flow | $-0.12MM | $-0.08MM | $0.00MM |
| Financing Cash Flow | $1.40MM | $2.35MM | $1.70MM |
| Earnings Per Share** | $-0.04 | $0.01 | $-0.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.